Clinical Trials Logo

Clinical Trial Summary

Vitreous floaters are tiny, cloudy, clumps of cells that appear in the otherwise clear fluid (vitreous) that fills the back 3/4 of the eye. Floaters are commonly caused by eye conditions such as posterior vitreous detachment (PVD), vitreous syneresis and asteroid hyalosis. While these symptoms are considered physiological in nature, they can be of considerable inconvenience to many patients which affect essential activities. The investigators wish to assess the safety and efficacy of floater treatment in patients with highly symptomatic floaters using an FDA approved nanosecond infrared yttrium aluminum garnet (YAG) lasers.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01970267
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date February 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04727398 - The Incidence of Complete Posterior Vitreous Degeneration After Phacoemulsification N/A
Completed NCT01415037 - Annular Array Ultrasound in Ophthalmology
Completed NCT00408720 - Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies N/A
Recruiting NCT04719871 - Vitreous Detachment and Glaucoma Progression
Recruiting NCT02290795 - Vitreopapillary Interface and Optic Disc Morphology N/A
Not yet recruiting NCT04726267 - Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy. N/A
Completed NCT02897583 - YAG Vitreolysis for Floaters N/A
Completed NCT00633854 - High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging
Terminated NCT02681809 - A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR Phase 2
Completed NCT00831350 - Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Phase 2